Investor Evans Daron
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Evans Daron . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2021-06-11 13D/A NEPH / Nephros, Inc. 473,064 478,874
2020-04-08 13D NEPH / Nephros, Inc. 473,064
2018-01-04 13G/A VKTX / Viking Therapeutics, Inc. 1,286,173 26,087
2017-02-17 13G VKTX / Viking Therapeutics, Inc. 1,286,173